Novo Nordisk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. 

CEO
Maziar Mike Doustdar
CEOMaziar Mike Doustdar
Employees
76,302
Employees76,302
Headquarters
Bagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded
1923
Founded1923
Employees
76,302
Employees76,302

NVO Key Statistics

Market cap
270.03B
Market cap270.03B
Price-Earnings ratio
17.10
Price-Earnings ratio17.10
Dividend yield
2.09%
Dividend yield2.09%
Average volume
19.81M
Average volume19.81M
High today
$60.87
High today$60.87
Low today
$59.10
Low today$59.10
Open price
$60.13
Open price$60.13
Volume
19.31M
Volume19.31M
52 Week high
$93.80
52 Week high$93.80
52 Week low
$43.08
52 Week low$43.08

NVO News

TipRanks 7h
Mixed options sentiment in Novo Nordisk with shares up 1.79%

Mixed options sentiment in Novo Nordisk (NVO), with shares up $1.05, or 1.79%, near $59.87. Options volume roughly in line with average with 89k contracts trade...

TipRanks 9h
Novo Nordisk Rethinks Pricing as Compounded GLP-1 Drugs Gain Ground

Novo Nordisk (NVO) CEO Mike Doustdar said that as many as 1.5 million people in the U.S. may now be using compounded versions of popular GLP-1 weight-loss drugs...

Simply Wall St 14h
Novo Nordisk Valuation Check After Recent Share Price Strength And Long Term Growth Narrative

Novo Nordisk (NVO) stock has recently drawn attention after a positive single-day move of about 2.6%, adding to gains over the past week and month that investor...

Novo Nordisk Valuation Check After Recent Share Price Strength And Long Term Growth Narrative

Analyst ratings

53%

of 34 ratings
Buy
52.9%
Hold
35.3%
Sell
11.8%

More NVO News

The Motley Fool 2d
This Healthcare Stock Could Be One of the Best Companies to Own in 2026

It has strong momentum thanks to its current portfolio and several catalysts on the horizon. Over the past five years, Eli Lilly (LLY 1.90%) has been on a tear...

This Healthcare Stock Could Be One of the Best Companies to Own in 2026
TipRanks 3d
Amazon Begins Selling Novo Nordisk’s Weight-Loss Pill

E-commerce giant Amazon (AMZN) has announced that it is now selling Novo Nordisk’s (NVO) new weight-loss pill through its digital pharmacy. Claim 70% Off TipRa...

Barchart 3d
Novo Nordisk Is Getting a Major Boost from Amazon for Its New Wegovy Pill. Does That Make NVO Stock a Buy Here?

...

TipRanks 3d
Novo Nordisk Stock Jumps as Amazon Begins Selling Obesity Pill

Danish pharma giant Novo Nordisk’s (NVO) shares bubbled with life on Friday afternoon as retail giant Amazon’s (AMZN) digital pharmacy kicked off the sale of it...

CNBC 3d
Amazon Pharmacy starts offering Novo Nordisk's Wegovy weight-loss pill

Amazon announced Friday it now offers Novo Nordisk 's Wegovy weight-loss pill through its digital pharmacy. Novo Nordisk began rolling out an oral version of i...

Amazon Pharmacy starts offering Novo Nordisk's Wegovy weight-loss pill
The Wall Street Journal 4d
Amazon Pharmacy Begins Offering Wegovy Pill

Novo Nordisk and Eli Lilly agreed to make their weight-loss pills available for direct-to-consumer purchase at starting doses of $149 a month. Gabby Jones/Bloom...

Amazon Pharmacy Begins Offering Wegovy Pill
TipRanks 4d
Novo Nordisk Expands CagriSema Push Into Youth Diabetes: Early Trial Update for Investors

Novo Nordisk (NVO) announced an update on their ongoing clinical study. Claim 70% Off TipRanks Premium Novo Nordisk Targets Youth Diabetes With New CagriSema...

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.